Domo (NASDAQ: DOMO) Founder and Chief Executive Officer Joshua James has completed a transaction involving the disposal of 96,088 shares of the company's Class B Common Stock. The filing confirms the transaction occurred on June 24, 2026, with the total proceeds amounting to $228,458. The shares were sold at a weighted average price of $2.3776, with the individual sale prices ranging between $2.185 and $2.640. According to the regulatory filing, the primary purpose of this divestment was to satisfy specific tax obligations incurred during the vesting and settlement process of Restricted Stock Units.
Post-transaction, Mr. James maintains a direct holding of 1,638,873 shares of Class B Common Stock. His ownership footprint extends significantly through indirect channels, reflecting a complex structure of equity control. Through Cocolalla, LLC, of which he serves as manager, he holds indirect ownership of 3,263,659 shares of Class A Common Stock. These Class A shares possess the unique characteristic of being convertible into Class B Common Stock on a one-to-one basis at his election, with no expiration date attached to this conversion right. As the manager of Cocolalla, LLC, Mr. James retains full voting and dispositive power over these shares. Additional indirect stakes include 429,810 shares via Cocolalla, LLC, 116,600 shares held by the James Family Charitable Remainder Trust, 2,143 shares attributed to his spouse, and 10,000 shares through Cinnamon Birch LLC.
This executive share sale occurs against a backdrop of significant market and financial headwinds for Domo. The company's stock has experienced substantial depreciation, trading at $2.75 and reflecting a 78% decline over the past year. This price action has compressed the company's market capitalization to $126 million. Despite the bearish market performance, some analytical frameworks suggest the stock may be undervalued at current levels, with projections indicating a potential return to profitability within the current fiscal year. The platform's analytical tools, including Pro Research Reports, claim to transform complex data into actionable insights for over 1,400 US stocks, though this does not alter the immediate financial realities faced by the company.
Financially, Domo reported its fiscal first-quarter results for 2027, which revealed a revenue miss. The company generated $79.4 million in revenue, falling slightly short of the anticipated $79.58 million. However, the company managed to post a narrower-than-expected loss of 2 cents per share, beating analyst predictions of an 8-cent loss. A more critical operational challenge involves a breach of its annual recurring revenue loan covenant. This breach has prompted a forbearance agreement with its lender, which is contingent upon the company signing a sale transaction agreement by July 31. The timeline for any such strategic transaction remains uncertain.
Analyst reactions to these developments have been mixed, with several firms adjusting their ratings and price targets. TD Cowen downgraded Domo from Buy to Hold, reducing its price target to $3.25. Citizens lowered its price target to $2.25, maintaining a Market Underperform rating. Cantor Fitzgerald adjusted its price target downward from $8.00 to $5.00 but retained an Overweight rating, emphasizing the company's mixed results and ongoing strategic transaction review. D.A. Davidson maintained a Neutral rating with a $3.50 price target, highlighting the revenue miss and variability in deal timing as key factors.
Key Points
- Executive Divestment Structure: Joshua James sold 96,088 shares to cover tax liabilities from Restricted Stock Unit settlements, retaining significant direct and indirect control over Domo's equity through Cocolalla, LLC and family trusts.
- Financial Performance and Covenant Breach: Domo reported a fiscal Q1 2027 revenue miss of $79.4 million against $79.58 million expectations, alongside a breach of its annual recurring revenue loan covenant requiring a sale agreement by July 31.
- Analyst Downgrades and Market Pressure: Multiple analysts have adjusted price targets downward following the revenue miss and covenant breach, reflecting concerns over the company's financial stability and strategic uncertainty.
Risks and Uncertainties
- Covenant Breach and Sale Contingency: The breach of the annual recurring revenue loan covenant introduces significant risk, as the forbearance agreement hinges on signing a sale transaction agreement by July 31. Failure to meet this deadline could trigger lender actions.
- Strategic Uncertainty and Market Valuation: The company's exploration of strategic options, combined with a 78% stock decline and compressed market cap, creates uncertainty for investors regarding future valuation and operational direction.
- Revenue Variability and Analyst Skepticism: The revenue miss and variability in deal timing, as noted by D.A. Davidson, highlight ongoing operational challenges that may impact investor confidence and future capital raising efforts.